The centre will help discover new treatments to prevent, halt and cure the condition
News
NHS expands COVID-19 research platform for other major diseases
The OpenSAFELY platform will support the discovery of new treatments
New NIHR Research Delivery Network in England announced by DHSC
The University of Leeds and NHS organisations will host the network in 2024
NHS trials artificial intelligence system to prevent avoidable admissions
The AI system will identify those most at risk and reduce pressure on the NHS
LifeArc and UKDRI invest £14.5m into neurodegeneration research
The funding will be used to develop new diagnostic tests, treatments and devices
Glox Therapeutics secures £4.3m seed funding to combat AMR
The bacteriocin development programme will first target pseudomonas aeruginosa
JCVI advises UK government on gonorrhoea and mpox vaccinations
Both programmes will be offered to those most at risk of developing STIs
Study shows how congenital heart disease affects blood supply before birth
CHD is a common birth defect that affects the development of the heart and brain
Documentary highlights new targets to potentially treat motor neurone disease
The terminal condition currently affects around 5,000 people in the UK
BBSRC to invest £12m into 62 UK bioscience research projects
The projects will explore early-stage ideas at the frontiers of bioscience
Sandoz opens new antibiotic and biosimilar facilities in Austria and Germany
Antimicrobial resistance is considered one of the top ten global public health threats
IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial
The trial is evaluating an investigational cancer vaccine in combination with Keytruda
SynaptixBio says NHS diagnostic service for rare diseases could be expanded
A rare disease is defined as a condition that affects fewer than one in 2,000 people
100th patient joins ChariotMS trial for multiple sclerosis
The trial is testing whether Mavenclad could benefit upper limb movement in MS patients
New womb cancer test could prevent need for invasive diagnostic procedures
The WID-qEC test successfully identified 91% of womb cancer cases
